HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (NASDAQ:PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that a scientific ...
Pulse Biosciences' Nano-Pulse Stimulation technology is showing promise in various treatments. The company is also exploring the use of its nsPFA technology in treating atrial fibrillation, ...
Pulsetto is emerging as a notable development within the expanding field of non-invasive wellness technology, particularly in the area of nervous system regulation. As global attention continues to ...
Pulsetto, a leader in Vagus Nerve Stimulation technology, is showcasing at CES its unique dual-technology system and personalized app designed to alleviate stress, reduce anxiety, improve sleep, and ...
Pulsetto - known for delivering non-invasive, cervical vagus nerve stimulation through a hands-free, app-enabled wearable that promotes stress relief, mental clarity, and sleep support. The links in ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX ® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology (“Pulse”), today ...
The first-of-a-kind brain-stimulation device approved to treat attention-deficit/hyperactivity disorder (ADHD) in the US has ...
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Pulse Biosciences, Inc. is one of them. Pulse Biosciences, Inc. (NASDAQ:PLSE) is advancing bioelectric medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results